Molecularly imprinted solid-phase extraction for the selective determination of methamphetamine, amphetamine, and methylenedioxyphenylalkylamine designer drugs in human whole blood by gas chromatography-mass spectrometry

Journal of Separation Science

Volumn 35, Issue 5-6, 2012, Pages 726-733

  Kumazawa, Takeshi ^a   Hasegawa, Chika ^b   Hara, Kenji ^c   Uchigasaki, Seisaku ^d   Lee, Xiao Pen ^a   Seno, Hiroshi ^e   Suzuki, Osamu ^f   Sato, Keizo ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amphetamines; GC; Human whole blood; Molecularly imprinted polymer solid phase extraction; MS

Indexed keywords

AMPHETAMINES; GC; MS; SOLID-PHASE EXTRACTION; WHOLE BLOOD;

AMMONIUM COMPOUNDS; DESIGN; DRUG PRODUCTS; FORMIC ACID; GAS CHROMATOGRAPHY; PHASE SEPARATION; PROJECTILES;

BLOOD;

3,4 (METHYLENEDIOXYPHENYL) 2 BUTANAMINE; 3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYAMPHETAMINE DERIVATIVE; 3,4 METHYLENEDIOXYETHYLAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMMONIUM ACETATE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; DESIGNER DRUG; FORMIC ACID; METHAMPHETAMINE; METHANOL; N METHYL 1 (3,4 METHYLENEDIOXYPHENYL) 2 BUTANAMINE; PHENYLALKYLAMINE; TRIFLUOROACETIC ANHYDRIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION COEFFICIENT; DERIVATIZATION; EXTRACTION; HUMAN; MASS FRAGMENTOGRAPHY; MOLECULAR IMPRINTING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SOLID PHASE EXTRACTION;

3,4-METHYLENEDIOXYAMPHETAMINE; ADSORPTION; AMPHETAMINE; AMPHETAMINES; DESIGNER DRUGS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MOLECULAR IMPRINTING; POLYMERS; SOLID PHASE EXTRACTION;

EID: 84860172678     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.201100924     Document Type: Article

References (37)

1. Valter, K., Arrizabalaga, P., Designer Drugs Directory, Elsevier Science S.A., Lausanne 1998.
2. Fineschi, V., Centini, F., Mazzeo, E., Turillazzi, E., Forensic Sci. Int. 1999, 704, 65-74.
3. Carter, N., Rutty, G. N., Milroy, C. M., Forrest, A. R. W., Int. J. Legal Med. 2000, 113, 168-170.
4. Pilgrim, J. L., Gerostamoulos, D., Drummer, O. H., Bollmann, M., J. Forensic Sci. 2009, 54, 478-485.
5. Milroy, C. M., Forensic Sci. Med. Pathol. 2011, 7, 248-252.
6. Wu, L.-T., Ringwalt, C.-L., Mannelli, P., Am. J. Addict. 2008, 77, 354-363.
7. Schifano, F., Corkery, J., Naidoo, V., Oyefeso, A., Ghodse, H., Neuropsychobiology 2010, 61, 122-130.
8. Yamamoto, B. K., Moszczynska, A., Gudelsky, G. A., Ann. NY Acad. Sci. 2010, 1187, 101-121.
9. Mohamed, W. M. Y., Hamida, S. B., Cassel, J.-C., de Vasconcelos, A. P., Jones, B. C., Pharm. Biochem. Behav. 2011, 99, 759-774.
10. Cocheiro, M., de Castro, A., Quintela, O., Lopez-Riva-dulla, M., Cruz, A., Forensic Sci. Int. 2005, 150, 221-226.
11. Gunnar, T., Ariniemi, K., Lillsunde, P., J. Mass Spectrom. 2005, 40, 739-753.
12. Concheiro, M., de Castro, A., Quintela, O'., Lopez-Riva-dulla, M., Cruz, A., J. Chromatogr. B 2006, 832, 81-89.
13. Kudo, K., Ishida, T., Hikiji, W., Hayashida, M., Uekusa, K., Usumoto, Y., Tsuji, A., Ikeda, N., Forensic Toxicol. 2009, 27, 21-31.
14. Moriya, F., Forensic Toxicol. 2010, 28, 43-46.
15. Bassan, D. M., Erdmann, F., Kriill, R., Anal. Bioanal. Chem. 2011, 400, 43-50.
16. Kumazawa, T., Hasegawa, C., Lee, X.-P., Sato, K., Forensic Toxicol. 2010, 28, 61-68.
17. Augusto, F., Carasek, E., Costa Silva, R. G., Rivellino, S. R., Batista, A. D., Martendal, E., J. Chromatogr. A 2010, 1217, 2533-2542.
18. Ramstrom, O., Mosbach, K., Curr. Opin. Chem. Biol. 1999, 3, 759-764.
19. Mayes, A. G., Whitcombe, M. J., Adv. Drug Deliv. Rev. 2005, 57, 1742-1778.
20. Tamayo, F. G., Turiel, E., Martin-Esteban, A., J. Chromatogr. A 2007, 1152, 32-40.
21. Lasakova, M., Jandera, P., J. Sep. Sci. 2009, 32, 799-812.
22. Caro, E., Marce, R. M., Cormack, P. A. G., Sherrington, D.C., Borrull, F., J. Chromatogr. B 2004, 813, 137-143.
23. Wu, S. G., Lai, E. P. C., Mayer, P. M., J. Pharm. Biomed. Anal. 2004, 36, 483-490.
24. Yang, J., Hu, Y., Cai, J.-B., Zhu, X.-L., Su, Q.-D., Anal. Bioanal. Chem. 2006, 384, 761-768.
25. Hu, X., Pan, J., Hu, Y., Li, G., J. Chromatogr. A 2009, 1216, 190-197.
26. Shah, K. A., Halquist, M. S., Karnes, H. T., J. Chromatogr. B 2009, 877, 1575-1582.
27. Lasáková, M., Thiébaut, D., Jandera, P., Pichon, V., J. Sep. Sci. 2009, 32, 1036-1042.
28. Moein, M. M., Javanbakht, M., Akbari-adergani, B., J. Chromatogr. B 2011, 879, 777-782.
29. González-Marino, I., Quintana, J. B., Rodríguez, I., Rodil, R., González-Peńas, J., Cela, R., J. Chromatogr. A 2009, 7276, 8435-8441.
30. U.S. Department of Health and Human Services, Food and Drugs Administration, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Guidance for Industry: Bioanalytical Method Validation, 2001.
31. Kumazawa, T., Hara, K., Hasegawa, C., Uchigasaki, S., Lee, X.-P., Seno, H., Suzuki, O., Sato, K., Int. J. Spectrosc. 2011, Article ID 318148, 2011. DOI: 10.1155/2011/318148.
32. Maquille, A., Guillarme, D., Rudaz, S., Veuthey, J.-L., Chromatographia 2009, 70, 1373-1380.
33. Hasegawa, C., Kumazawa, T., Lee, X.-P., Marumo, A., Shinmen, N., Seno, H., Sato, K., Anal. Bioanal. Chem. 2007, 389, 563-570.
34. Schulz, M., Schmoldt, A., Pharmazie 2003, 58, 447-474.
35. Maurer, H. H., Bickeboeller-Friedrich, J., Kraemer, T., Peters, F.T., Toxicol Lett. 2000, 112-113, 133-142.
36. Kalant, H., Can. Med. Assoc. J. 2001, 165, 917-928.
37. Moffat, A. C., Jackson, J. V., Moss, M. S., Widdop, B., (Eds.), Clarke's Analysis of Drugs and Poisons (3rd Edn.), Pharmaceutical Press, London 2004, p. 1254.